Single Dose Study of PF-06815345 in Healthy Subjects

Summary

The current study is the first clinical trial proposed with PF-06815345. It is designed to evaluate the safety, tolerability, and pharmacokinetics (PK) following administration of single oral doses of PF-06815345 to healthy adult subjects.

Timeline

Start

2015-11

Primary completion

2016-03

Completion

2016-03

Outcome

Outcome not reported

Stopped (Business): “Trial discontinued on 04Apr2016 as a strategic business decision not to pursue the indication. Decision to terminate not due to safety or efficacy concerns.”

Drugs

Indications